Skip to content
Alignodontic DPS

Aligner labs4 min read

Planning clear aligner cases for dental laboratories

How a laboratory can add aligner planning capacity: intake from many doctors, batch handling, production-ready output, and keeping approval with the clinician.

By Prof. Dr. Ali Raza Jafri

A laboratory offering clear aligners sits between two constraints. Its clients are doctors who need plans they can review and approve, and its own production line needs files it can print and thermoform without rework. Planning is the hinge between the two, and the laboratories that scale are usually the ones that made that hinge explicit rather than heroic.

What is different about the laboratory setting

Three things. The volume arrives in batches rather than one case at a time. The prescriptions come from many doctors with different conventions, different levels of detail and different tolerance for being asked questions. And the output is not a plan for its own sake; it is an input to a machine with its own requirements. A workflow that suits a single practice planning its own cases handles none of these well.

Intake from many doctors

The single highest-value thing a laboratory can standardise is intake. A consistent submission — upper, lower and bite scans in an agreed format, photographs, radiographs where relevant, and a written prescription that names objectives and constraints — turns a variable input into a predictable one. Publish it, and give doctors a short form that asks the questions they would otherwise forget: what to correct, what must not move, limits on IPR and expansion, position on attachments in the aesthetic zone.

Build the scan check into intake rather than into planning. Catching an unusable mesh at receipt costs a message; catching it after segmentation costs the segmentation and a day of the schedule. It also protects the relationship, because a doctor told immediately that a scan needs repeating can often see the patient that week.

Handling cases in batches

  • Case references that sort and search, so a case can be found by number rather than by patient name.
  • A visible status per case, so nobody has to ask where anything is.
  • Grouping by doctor for review, since a doctor reviewing five of their cases in one sitting is faster than five separate rounds.
  • A queue for cases waiting on the doctor, kept separate from cases waiting on the laboratory, so the bottleneck is always visible.
  • Version history per case, because at volume nobody remembers what changed in round two.

Keep patient identifiers out of the pipeline. A case reference is enough for planning and production, it is easier to protect, and it avoids a laboratory holding a register of other practices' patients that it has no reason to hold.

Production-ready output

What the planning end produces has to match what the production end consumes. Agree, and write down, the model format and mesh density for printing, whether the models are solid or hollowed and with what wall thickness, whether a base is added and of what height, how attachments are represented, how stages are named and numbered, and how the template aligner for attachment bonding is generated. Every one of these is a routine detail until a batch of approved cases arrives shaped wrongly for the printer.

Number stages the same way in the plan, on the printed model and on the pouch. Cases lose more time to a stage-numbering mismatch between planning and packaging than to almost any planning error.

Approval stays with the clinician

This is the part a busy laboratory is most tempted to soften, and the part it should not. The laboratory prepares the plan; the treating clinician reviews and approves it; only the approved version goes into production. A laboratory that approves on a doctor's behalf to keep the queue moving has taken on a clinical decision it is not in a position to make, and has removed the review that would have caught the error before it was thermoformed forty times.

Practically, that means the approval must be attributable to a named clinician and tied to a specific version, and production must reference that version. It also means chasing is part of the job: a clear status, a reminder, and a plan that is quick to review are how you get approvals back without asking anyone to skip the review.

Communicating with doctors at volume

A laboratory is talking to many clinicians with different expectations, and most of the friction is about status rather than clinical content. Doctors want to know that a case arrived, that it is being worked on, that it is waiting for them, and that production has started. A visible status per case answers all four without a phone call. Keeping clinical discussion attached to the case, by tooth and by stage, rather than in email, has the same effect on the planning side: the next person to open the case can see why it looks the way it does.

Building capacity, buying it, or both

A laboratory can employ planners, outsource planning, or do both. Employing gives control and, at steady high volume, better economics, but it carries the same fragility any small specialist team does: holidays, illness and turnover all become production incidents. Outsourcing absorbs peaks and unusual case types without carrying the fixed cost. Many laboratories run a standard case type in-house and send the overflow and the awkward cases out, which keeps the internal team fast at what it does most.

Whichever way capacity is arranged, the same requirements apply to the plans themselves: a movement table, an attachment list, an IPR schedule, stated staging limits and an intact version history. What a digital treatment plan should include sets those out in full.

Ready to start your next case?

Create the case, upload the scans and review the plan online.

Submit a case